gila monster glp 1 discovery Did you know? The first GLP-1 medication for type 2 Why Useless Knowledge Can Be

GHK-Cu (50 mg) is a synthetic research peptidecopper complex used in healing and regenerative research

Type I interferons in systemic lupus erythematosus: a journey from bench to bedside

Originally developed for the treatment of type 2 diabetes mellitus, these agentsincluding semaglutide and tirzepatidehave demonstrated substantial efficacy in promoting weight loss and are increasingly reshaping therapeutic strategies for obesity, cardiovascular and kidney disease, and potentially substance use disorders.[1,2] Historically, paradigm-shifting therapeutics have periodically redefined clinical practice

[DOI] [PubMed] [Google Scholar] 118.Wattanathorn J., Chonpathompikunlert P., Muchimapura S., Priprem A., Tankamnerdthai O